Aptose Biosciences Inc.

5.12+0.0700+1.39%Vol 1.02M1Y Perf -24.15%
Apr 13th, 2021 16:00 DELAYED
BID5.12 ASK5.13
Open5.11 Previous Close5.05
Pre-Market- After-Market5.26
 - -  0.14 2.73%
Target Price
10.67 
Analyst Rating
Strong Buy 1.00
Potential %
108.40 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
 —    -
Market Cap454.86M 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
30.84 
Earnings Date
4th May 2021

Today's Price Range

4.965.14

52W Range

3.399.00

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-9.06%
1 Month
29.62%
3 Months
16.63%
6 Months
-12.93%
1 Year
-24.15%
3 Years
55.62%
5 Years
89.63%
10 Years
-

TickerPriceChg.Chg.%
APTO5.120.07001.39
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.16-0.17-6.25
Q03 2020-0.18-0.1516.67
Q02 2020-0.15-0.21-40.00
Q01 2020-0.10-0.15-50.00
Q04 2019-0.14-0.137.14
Q03 2019-0.13-0.127.69
Q02 2019-0.14-0.137.14
Q01 2019-0.17-0.1417.65
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.1810.00Positive
6/2021 QR-0.195.00Positive
12/2021 FY-0.801.23Positive
12/2022 FY-1.13-9.71Negative
Next Report Date4th May 2021
Estimated EPS Next Report-0.18
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume1.02M
Shares Outstanding88.84M
Trades Count7.84K
Dollar Volume5.43M
Avg. Volume4.00M
Avg. Weekly Volume1.51M
Avg. Monthly Volume11.34M
Avg. Quarterly Volume4.39M

Aptose Biosciences Inc. (NASDAQ: APTO) stock closed at 5.12 per share at the end of the most recent trading day (a 1.39% change compared to the prior day closing price) with a volume of 1.02M shares and market capitalization of 454.86M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 31 people. Aptose Biosciences Inc. CEO is William G. Rice.

The one-year performance of Aptose Biosciences Inc. stock is -24.15%, while year-to-date (YTD) performance is 16.89%. APTO stock has a five-year performance of 89.63%. Its 52-week range is between 3.39 and 9, which gives APTO stock a 52-week price range ratio of 30.84%

Aptose Biosciences Inc. currently has a PE ratio of -, a price-to-book (PB) ratio of 22.49, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -46.88%, a ROC of -61.33% and a ROE of -49.95%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Aptose Biosciences Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.18 for the next earnings report. Aptose Biosciences Inc.’s next earnings report date is 04th May 2021.

The consensus rating of Wall Street analysts for Aptose Biosciences Inc. is Strong Buy (1), with a target price of $10.67, which is +108.40% compared to the current price. The earnings rating for Aptose Biosciences Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Aptose Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Aptose Biosciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 14.67, ATR14 : 0.30, CCI20 : -5.97, Chaikin Money Flow : -0.05, MACD : -0.01, Money Flow Index : 87.85, ROC : -12.93, RSI : 36.49, STOCH (14,3) : 7.14, STOCH RSI : 0.86, UO : 38.68, Williams %R : -92.86), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Aptose Biosciences Inc. in the last 12-months were: Gregory K. Chow (Sold 126 668 shares of value $766 341 ), Jotin Marango (Sold 83 781 shares of value $512 945 ), Warren Whitehead (Option Excercise at a value of $115 575), Warren Whitehead (Sold 80 000 shares of value $526 200 ), William G. Rice (Sold 168 891 shares of value $1 021 790 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (100.00 %)
4 (100.00 %)
4 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Aptose Biosciences Inc.

Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.

CEO: William G. Rice

Telephone: +1 650 718-5028

Address: 251 Consumers Road, Toronto M2J 4R3, ON, CA

Number of employees: 31

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

46%54%

Bearish Bullish

57%43%

News

Stocktwits